These ASX shares could rise 20% to 60%

Analysts see major upside potential for these stocks.

| More on:
A man sees some good news on his phone and gives a little cheer.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you hunting big returns for your investment portfolio? Of course you are! Who isn't?

Well, I have some good news for you.

The three ASX shares that are listed below have been tipped to rise 20% to 60% from current levels. This is significantly greater than the historical average annual market return of 10%.

Here's what analysts are tipping from these ASX shares:

Neuren Pharmaceuticals Ltd (ASX: NEU)

Analysts at Bell Potter think huge returns could be on the cards for buyers of this pharmaceuticals company's shares.

Last week, its analysts retained their buy rating and $25.00 price target on the ASX share. Based on its current share price of $15.57, this suggests that upside of 60% is possible for investors.

Bell Potter remains very positive on the company due to its NNZ-2591 product candidate.

Its analysts advised that they "continue to view NNZ-2591 as a valuable asset that is likely to start one, if not two, Phase 3 trials in CY25 in attractive orphan indications. We maintain our $25/share PT of which ~$10/share is attributed to Daybue licensing income."

Origin Energy Ltd (ASX: ORG)

Another ASX share that could generate big returns is energy giant Origin Energy.

In response to its full year results last week, analysts at UBS retained their buy rating on the company's shares with a slightly trimmed price target of $11.70.

Based on its current share price of $9.66, this implies potential upside of 21% for investors over the next 12 months. In addition, a dividend yield greater than 5% is expected in FY 2025, which boosts the total return further.

Rio Tinto Ltd (ASX: RIO)

Finally, Goldman Sachs thinks that this mining giant could generate big returns for investors over the next 12 months.

The broker currently has a buy rating and $136.60 price target on Rio Tinto's shares. This implies potential upside of 24% for investors between now and this time next year. In addition, Goldman is forecasting a 6% dividend yield over the period, which stretches the total potential return to 30%.

Its analysts highlight that "RIO is a FCF and production growth story in our view, with forecast Cu Eq production growth of ~4-7% in 2025 & 2026 driven mostly by the ramp-up of the Oyu Tolgoi UG copper mine & a recovery at Escondida and Bingham, higher Pilbara Fe shipments with the ramp-up of new mines, and a rebound in aluminium production."

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the 'five best ASX stocks' for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now...

See The 5 Stocks *Returns as of 3 April 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man presses green buy button and red sell button on a graph.
Broker Notes

5 top ASX 200 stocks that brokers rate as buys after the market selloff

These stocks could be top buys for investors looking to add to their portfolio.

Read more »

Health professional putting on gloves.
Healthcare Shares

How will Ansell shares navigate tariffs according to Macquarie?

The next two years could be a challenging period for the PPE company.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Broker Notes

3 of the very best ASX shares to buy now

These shares are highly rated by the team at Bell Potter for a reason.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man working in the stock exchange.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Three miners stand together at a mine site studying documents with equipment in the background
Resources Shares

What does Macquarie think Fortescue shares are worth?

Is the iron ore giant about to turn a corner?

Read more »

A young couple sits at their kitchen table looking at documents with a laptop open in front of them while they consider the state of their investments.
Broker Notes

AGL shares: a potential beneficiary of the Federal Government's proposed household battery subsidy?

Is this plan going to recharge investor excitement about AGL?

Read more »